Par Drugs and Chemicals IPO offer price is ₹ 51.00 and got listed at ₹ 51.45. Read IPO details mentioned above.
Par Drugs and Chemicals IPO listing price is ₹ 51.45, issue price is ₹ 51.00, and currently trading at ₹ 99.41 as on 5 march 2025. Infraprime Logistics IPO performance is show below with lates CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Par Drugs and Chemicals IPO is a Fixed Price listing on NSE EMERGE exchange. The company is based in Vadodara and caters to Pharmaceutical sector. Pantomath Capital Advisors is the merchant banker of Par Drugs and Chemicals IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 29th March 2019.
Par Drugs and Chemicals IPO offer price is ₹ 51.00 and got listed at ₹ 51.45. Read Infraprime Logistics Technologies IPO details mentioned above.Par Drugs and Chemicals IPO, based in Vadodara, operates in the Pharmaceutical sector with a focus on . The company is launching its SME IPO on the NSE EMERGE exchange, using the Fixed Price Issue method. Par Drugs and Chemicals IPO size is ₹ 8.53 Cr. with fresh issue size of ₹ 8.53 Cr. and Offer for sale being Nil
The IPO allotment date for Par Drugs and Chemicals IPO is expected to be 13th May 2019, after the finalization of basis of allotment. Investors can check Par Drugs and Chemicals IPO allotment status on the registrars website, Link Intime India Private Limited. Par Drugs and Chemicals IPO refund dates are 14th May 2019.
Par Drugs and Chemicals IPO is expected to be listed on 16th May 2019.
The upper price band for the Par Drugs and Chemicals IPO is set at ₹ 51.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Par Drugs and Chemicals IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Par Drugs and Chemicals IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 8th May 2019. After submission, funds are blocked until the basis of allotment of Par Drugs and Chemicals IPO is finalised.
The merchant banker for Par Drugs and Chemicals IPO is Pantomath Capital Advisors Private Limited . Pantomath Capital Advisors Private Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Par Drugs and Chemicals IPO RHP for further details.
The registrar for Par Drugs and Chemicals IPO is Link Intime India Private Limited. Investors can go to Link Intime India Private Limited registrar website for IPO allotment status, refund processing, and other queries related to Par Drugs and Chemicals IPO through their official website or helpline.
Par Drugs and Chemicals IPO was subscribed 5.74 times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
Listing Gain
Issue Price vs Listing Price:Market Performance
Issue Price vs CMP:Par Drugs and Chemicals IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Par Drugs and Chemicals Financial Review Page
Merchant Banker(s) of Par Drugs and Chemicals IPO: Pantomath Capital Advisors Private Limited
Par Drugs and Chemicals IPO subscription was 5.74 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Par Drugs and Chemicals IPO listed at a listing price of 51.45 against the offer price of 51.00.
The current market price of Par Drugs and Chemicals is 99.41.
Why Us?